World Health Organization. Diabetes. Geneva, Switzerland: WHO; 2024 [updated 2024; cited 2024 October 4]; Available from: https://www.who.int/health-topics/diabetes.

Baena-Díez JM, Peñafiel J, Subirana I, Ramos R, Elosua R, Marín-Ibañez A, et al. Risk of cause-specific death in individuals with diabetes: a competing risks analysis. Diabetes Care. 2016;39(11):1987–95.

Article  PubMed  Google Scholar 

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.

Article  Google Scholar 

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.

Article  CAS  PubMed  Google Scholar 

Imran SA, Agarwal G, Bajaj HS, Ross S. Targets for glycemic control. Can J Diabetes. 2018;42(Suppl 1):S42-6.

Article  PubMed  Google Scholar 

Yosef T, Nureye D, Tekalign E. Poor glycemic control and its contributing factors among type 2 diabetes patients at Adama Hospital Medical College in East Ethiopia. Diabetes Metab Syndr Obes. 2021;14:3273–80.

Article  PubMed  PubMed Central  Google Scholar 

Bitew ZW, Alemu A, Jember DA, Tadesse E, Getaneh FB, Sied A, et al. Prevalence of Glycemic Control and Factors Associated With Poor Glycemic Control: A Systematic Review and Meta-analysis. Inquiry. 2023;60:469580231155716.

Article  PubMed  Google Scholar 

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077–93.

Article  Google Scholar 

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.

Article  PubMed  Google Scholar 

Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89(2):465–71.

Article  CAS  PubMed  Google Scholar 

Lee RC, Wang Z, Heo M, Ross R, Janssen I, Heymsfield SB. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr. 2000;72(3):796–803.

Article  CAS  PubMed  Google Scholar 

Rech CR, Dellagrana RA, Nunes Marucci MF, Petroski EL. Validity of anthropometric equations for the estimation of muscle mass in the elderly. Rev Bras Cineantropom Desempenho Hum. 2012;14(1):23–31.

Google Scholar 

Trierweiler H, Kisielewicz G, Hoffmann Jonasson T, Rasmussen Petterle R, Aguiar Moreira C, Zeghbi Cochenski Borba V. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr. 2018;10:25.

Article  PubMed  PubMed Central  Google Scholar 

Lime-Ma F, Cotter JA, Schick EE. The effect of acute hyperglycemia on muscular strength, power and endurance. Int J Exerc Sci. 2017;10(3):390–6.

Article  PubMed  PubMed Central  Google Scholar 

Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, et al. Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study. J Am Med Dir Assoc. 2021;22(4):834-8.e1.

Article  PubMed  Google Scholar 

Yeung CHC, Au Yeung SL, Fong SSM, Schooling CM. Lean mass, grip strength and risk of type 2 diabetes: a bi-directional mendelian randomisation study. Diabetologia. 2019;62(5):789–99.

Article  PubMed  Google Scholar 

Qiao YS, Chai YH, Gong HJ, Zhuldyz Z, Stehouwer CDA, Zhou JB, et al. The association between diabetes mellitus and risk of sarcopenia: accumulated evidences from observational studies. Front Endocrinol (Lausanne). 2021;12:782391.

Article  PubMed  Google Scholar 

Nishimoto K, Doi T, Tsutsumimoto K, Nakakubo S, Kurita S, Kiuchi Y, et al. Relationship between Diabetes Status and Sarcopenia in Community-Dwelling Older Adults. J Am Med Dir Assoc 2022;23(10):1718.e7-.e12.

de Luis Román D, Garrachón Vallo F, Carretero Gómez J, López Gómez JJ, Tarazona Santabalbina FJ, Guzmán Rolo G, et al. [Decreased muscle mass in type-2 diabetes. A hidden comorbidity to consider]. Nutr Hosp 2023;40(1):59–66.

Pineda O, Stepenka V, Rivas-Montenegro A, Villasmil-Hernandez N, Añez R, Salazar J. Sarcopenia in patients with type 2 diabetes mellitus: a case–control study in Maracaibo city. Venez Int J Diabetes Dev Ctries. 2022;42:203–10.

Article  Google Scholar 

Bazo-Alvarez JC, Quispe R, Pillay TD, Bernabé-Ortiz A, Smeeth L, Checkley W, et al. Glycated haemoglobin (HbA(1c) ) and fasting plasma glucose relationships in sea-level and high-altitude settings. Diabet Med. 2017;34(6):804–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Izzo A, Massimino E, Riccardi G, Della Pepa G. A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors. Nutrients. 2021. https://doi.org/10.3390/nu13010183.

Article  PubMed  PubMed Central  Google Scholar 

Miranda JJ, Bernabe-Ortiz A, Smeeth L, Gilman RH, Checkley W. Addressing geographical variation in the progression of non-communicable diseases in Peru: the cronicas cohort study protocol. BMJ Open. 2012;2(1):e000610.

Article  PubMed  PubMed Central  Google Scholar 

American Diabetes Association Professional Practice Committee for Diabetes. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Supplement_1):S132-s49.

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 6. Glycemic targets: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S97-s110.

Article  PubMed  Google Scholar 

Ministerio de Salud. Guía de práctica clínica para el diagnóstico, tratamiento y control de la diabetes mellitus tipo 2 en el primer nivel de atención. Lima, Peru: MINSA; 2016.

IPAQ. IPAQ - International Physical Activity Questionnaire. IPAQ; 2022 [updated 2022; cited 2024 February 22]; Available from: https://sites.google.com/view/ipaq/home.

World Health Organization. Overweight and obesity. Geneva, Switzerland: WHO; 2024 [updated 2024; cited 2024 March 22]; Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.

Article  CAS  PubMed  Google Scholar 

Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, Okumura S, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010;110(1):57–65.

Article  CAS  PubMed  Google Scholar 

Sugimoto K, Tabara Y, Ikegami H, Takata Y, Kamide K, Ikezoe T, et al. Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus. J Diabetes Investig. 2019;10(6):1471–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes Metab J. 2016;40(2):140–6.

Article  PubMed  PubMed Central  Google Scholar 

Mori K, Nishide K, Okuno S, Shoji T, Emoto M, Tsuda A, et al. Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis. BMC Nephrol. 2019;20(1):105.

Article  PubMed  PubMed Central  Google Scholar 

Tan NC, Sankari U, Ng CE, Koh YLE. Longitudinal study on the progression of muscle status among community-dwelling ambulatory older multiethnic Asians with type 2 diabetes mellitus. BMC Geriatr. 2022;22(1):446.

Article  PubMed  PubMed Central  Google Scholar 

Pechmann LM, Jonasson TH, Canossa VS, Trierweiler H, Kisielewicz G, Petterle RR, et al. Sarcopenia in type 2 diabetes mellitus: a cross-sectional observational study. Int J Endocrinol. 2020;2020:7841390.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liccini A, Malmstrom TK. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc. 2016;17(9):846–51.

Article  PubMed  Google Scholar 

Bernabe-Ortiz A, Carrillo-Larco RM, Gilman RH, Smeeth L, Checkley W, Miranda JJ. Skeletal muscle mass and all-cause mortality: findings from the CRONICAS cohort study. Trop Med Int Health. 2023;28(2):107–15.

Article  PubMed  PubMed Central  Google Scholar